Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Hepatitis01:25

Hepatitis

80
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
80
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

21
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion...
21
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

96
Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
96
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

1.5K
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
1.5K
Arboviral Encephalitis01:25

Arboviral Encephalitis

53
Arboviral encephalitis refers to brain inflammation caused by arthropod-borne viruses, particularly those transmitted through mosquito vectors. Among these, West Nile virus (WNV), a member of the Flaviviridae family, is a significant public health concern. WNV is an enveloped, positive-sense, single-stranded RNA virus. Human infection typically begins when an infected mosquito introduces the virus into the dermis during feeding. The primary transmission cycle involves birds as amplifying hosts...
53

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Long-term outcomes after nucleos(t)ide analogue cessation in chronic hepatitis B - follow-up from the RETRACT-B cohort.

Journal of hepatology·2026
Same author

The Potential Impact of the Kennedy v. Braidwood Supreme Court Decision on Hepatitis C Diagnosis and Treatment in the United States.

Gastro hep advances·2025
Same author

Partial cure of chronic hepatitis B: potential implications for HCC surveillance?

Gut·2025
Same author

Association of Metabolic Comorbidities With Fibrosis Severity and Fibrosis Regression in Patients With Chronic Hepatitis B.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2025
Same author

Predictors of hepatic flares after nucleos(t)ide analogue cessation - Results of a global cohort study (RETRACT-B study).

Journal of hepatology·2025
Same author

Prospective appraisal of clinical diagnostic algorithms for hepatocellular carcinoma surveillance in Chinese patients with chronic hepatitis B infection.

Scientific reports·2024
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026
Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026
Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026
Same journal

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Lancet (London, England)·2026
Same journal

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

Lancet (London, England)·2026
関連記事をすべて見る

関連する実験動画

Updated: Apr 27, 2026

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection
11:14

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection

Published on: November 7, 2018

21.5K

B型肝炎ウイルス感染症

Christian Trépo1, Henry L Y Chan2, Anna Lok3

  • 1Department of Hepatology, Croix-Rousse Hospital, Hospices Civils de Lyon, Lyon, France; INSERM U1052, Lyon, France.

Lancet (London, England)
|June 24, 2014
PubMed
まとめ
この要約は機械生成です。

B型肝炎ウイルスの感染は,全世界で30%に及ぶ. ワクチン接種は罹患率を低下させますが,長期の抗ウイルス治療は肝臓の損傷を逆転させ,癌のリスクを下げることができますが,HBsAgのクリアランスのための新しい治療法が必要です.

さらに関連する動画

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

2.2K
Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells
09:02

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells

Published on: June 5, 2020

6.8K

関連する実験動画

Last Updated: Apr 27, 2026

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection
11:14

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection

Published on: November 7, 2018

21.5K
A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

2.2K
Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells
09:02

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells

Published on: June 5, 2020

6.8K

科学分野:

  • 肝臓病理学 肝臓病理学
  • ウイルス学 ウイルス学 ウイルス学
  • 免疫学 免疫学とは

背景:

  • B型肝炎ウイルス (HBV) 感染症は,世界の健康問題であり,世界人口の約30%が感染の血清学的証拠を示しています.
  • HBVは血液や精液で伝染するDNAウイルスで,肝硬変や肝細胞癌のリスクを伴い,特に生前感染した患者では発生します.

研究 の 目的:

  • B型肝炎ウイルスの感染に関する現在の理解を要約し,その流行病学,伝播,病原性を含む.
  • ワクチン接種と抗ウイルス治療がHBV感染のアウトカムに与える影響を強調する.
  • 改善されたHBsAgクリアランスとウイルス学的治療のための新しい治療戦略の必要性を強調する.

主な方法:

  • 世界中でB型肝炎ウイルスの流行に関する疫学データのレビュー.
  • ホストの免疫応答がHBVの病原化とウイルス制御における役割を分析する.
  • 既存のワクチンおよび抗ウイルス治療の有効性の評価.
  • 慢性HBV感染における肝損傷と疾患進行のメカニズムについての議論.

主要な成果:

  • 1981年以来の幼児の普遍的なワクチン接種は,HBVの有病率の有意な減少につながりました.
  • HBVは直接的に細胞病原性ではありませんが,肝損傷はウイルスの複製と宿主の免疫反応の相互作用によるものです.
  • 長期の抗ウイルス治療は,肝炎の炎症を軽減し,肝硬変を逆転させ,肝細胞癌のリスクを低下させることができます.

結論:

  • B型肝炎ウイルスの感染は,継続的な管理と予防戦略を必要とする主要な公衆衛生上の懸念事項であり続けています.
  • 現在の治療法は,ウイルスの複製と疾患の進行を制御するのに有効ですが,完全なウイルス治療とHBsAgのクリアランスを達成することは依然として課題です.
  • 慢性B型肝炎感染者の治療結果を改善し,ウイルス学的治療法に向けて取り組むためには,さらなる研究と新しい治療法の開発が不可欠です.